AIM/OPTI (AIM/OPTI)

London Stock Exchange AIM: AIM/OPTI · GBX

GBX 5.52

-0.14 (-2.4%)· Recorded snapshot

Market cap	5.8M
Revenue (ttm)	1.3M
Net income (ttm)	-4.3M
EPS (ttm)	-GBX 0.04
Shares out	103.3M
Volume	12,221
Beta	1.78

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.3M
Net income (ttm): -4.3M
EPS (ttm): -GBX 0.04
Market cap: 5.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-65.2

P25 n/aP50 n/aP75 n/a

ROIC-23.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AIM/OPTI indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

GBP

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United Kingdom
Country code	UK
Earnings date	2026-12-18
Employees	9
Employees change	-1
Employees growth	-10%
Enterprise value	GBX 4.8M
Exchange	London Stock Exchange AIM
Financial currency	GBP
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2006
Industry	Biotechnology
Is primary listing	Yes
ISIN number	GB00BP0RTP38
Last earnings date	2025-12-17
Last refreshed	2026-10-28
Market cap	GBX 5.8M
Next earnings date	2026-12-18
Price	GBX 5.52
Price currency	GBX
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	aim/OPTI
Website	https://optibiotix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-76.43%
EV/Sales	3.76x
FCF / EV yield	-35.26%
FCF yield	-29.28%
P/B ratio	1.23x
P/S ratio	4.53x
Price / tangible book value	1.49x
Sector forward P/E	14.52x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-190.06%
EBITDA margin	-173.91%
Gross margin	53.65%
Operating margin	-190.06%
Pretax margin	-338.35%
Profit per employee	GBX -476,111
Revenue per employee	GBX 143,111
ROA	-21.37%
ROA (5Y)	-12.98%
ROCE	-49.7%
ROE	-65.19%
ROE (5Y)	-7%
ROIC	-23.28%
SBC / revenue	45.89%
Tax / revenue	-5.67%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	32.12%
Gross profit growth (Q)	25.41%
Gross profit growth 3Y	26.67%
Gross profit growth 5Y	-8.15%
Net income growth years	0
Revenue growth	11.9%
Revenue growth (Q)	21.9%
Revenue growth (QoQ)	11.49%
Revenue growth 3Y	23.19%
Revenue growth 5Y	-7.03%
Revenue growth quarters	4
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	GBX 208,000
EBIT	GBX -2.4M
EBITDA	GBX -2.2M
EPS	GBX -0.04
FCF per share	GBX -0.02
Free cash flow	GBX -1.7M
Free cash flow minus SBC	GBX -2.3M
Gross profit	GBX 691,000
Income taxes	GBX -73,000
Investing cash flow	GBX 1.4M
Net cash flow	GBX -310,000
Net income	GBX -4.3M
Operating cash flow minus SBC	GBX -2.3M
Operating income	GBX -2.4M
Revenue	GBX 1.3M
Stock-based compensation	GBX 591,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	8.89
Book value per share	GBX 0.05
Debt / equity	0
Long-term assets	GBX 3.5M
Long-term liabilities	GBX 200,000
Net cash (debt)	GBX 989,000
Net cash / market cap	16.95%
Net cash growth	-23.86%
Net debt / equity	-0.21
Piotroski F-Score	4
Shareholders' equity	GBX 4.7M
Tangible book value	GBX 3.9M
Tangible book value per share	GBX 0.04
Total assets	GBX 5.2M
Total cash	GBX 989,000
Total debt	GBX 0
Total liabilities	GBX 442,000
WACC	14.05%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.18
Current assets	GBX 1.7M
Current liabilities	GBX 242,000
Current ratio	6.83
Inventory turnover	1.53
Net working capital	GBX 422,000
Quick ratio	5.23
Working capital	GBX 1.4M
Working capital turnover	0.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.2%
Shareholder yield	0.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-91.45%
10Y return CAGR	-21.8%
10Y total return	-91.45%
150-day SMA	GBX 5.77
1D price change	-2.39%
1M price change	-5.73%
1M total return	-5.73%
1W price change	-2.39%
1W total return	-2.39%
1Y price change	-33.15%
1Y return CAGR	-33.17%
1Y total return	-33.15%
20-day SMA	GBX 5.75
200-day SMA	GBX 5.97
3M price change	-1.52%
3M total return	-1.52%
3Y price change	-83.29%
3Y return CAGR	-44.91%
3Y total return	-83.29%
50-day SMA	GBX 5.84
50-day SMA vs 200-day SMA	50under200
52-week high	GBX 9.00
52-week high date	2025-11-24
52-week low	GBX 4.50
52-week low date	2026-04-28
5Y price change	-88.39%
5Y return CAGR	-35%
5Y total return	-88.39%
6M price change	12.55%
6M total return	12.55%
All-time high	GBX 133.20
All-time high date	2018-08-08
All-time low	GBX 4.50
All-time low date	2026-04-28
Average true range (ATR)	GBX 0.18
Average volume	56.1K
Beta (1Y)	-0.03
Beta (2Y)	0.5
Beta (5Y)	1.78
Change from 52-week high	-38.72%
Change from 52-week low	22.56%
Change from all-time high	-95.86%
Change from all-time low	22.56%
Change from open	-0.09%
Day's gap	-2.3%
Dollar volume	GBX 67,399
High price	GBX 5.52
Low price	GBX 5.52
Monthly RSI	37.29
Open price	GBX 5.52
Previous close	GBX 5.65
Price vs 150-day SMA	-4.34%
Price vs 20-day SMA	-4%
Price vs 200-day SMA	-7.59%
Price vs 50-day SMA	-5.53%
Relative volume	0.22
RSI	34.97
Sharpe ratio	-0.57
Sharpe ratio (3Y)	-0.62
Sharpe ratio (5Y)	-0.22
Sortino ratio	-0.74
Sortino ratio (3Y)	-0.86
Sortino ratio (5Y)	-0.3
Volume	12.2K
Weekly RSI	42.62
YTD price change	-18.3%
YTD total return	-18.3%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	92.6M
Shares change (QoQ)	3.27%
Shares change (YoY)	-0.2%
Shares held by insiders	10.31%
Shares outstanding	103.3M

Deeper analysis on AIM/OPTI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AIM/OPTI report

Is a complete AIM/OPTI research report available?

No complete published report is available for aim/OPTI (AIM/OPTI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM/OPTI (AIM/OPTI)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/OPTI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/OPTI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AIM/OPTI

Frequently asked questions